You can buy or sell Dynavax and other stocks, options, and ETFs commission-free!
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development and commercialization of novel vaccines and immuno-oncology therapeutics. The firm focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA. The listed name for DVAX is Dynavax Technologies Corporation Common Stock.
52 Week High
52 Week Low
-$0.24 per share
Available Feb 25, After Hours